Feature|Articles|September 14, 2026

Top 3 Takeaways From WCLC 2026 That Patients Should Know

Fact checked by: CURE staff

WCLC 2026 brought new lung cancer data on HER2-mutant, PD-L1-positive and EGFR exon 20 insertion-positive non-small cell lung cancer. Here's what patients should know about three key studies.

The 2026 World Conference on Lung Cancer, held September 12 through 15 in Seoul, South Korea, brought together lung cancer specialists from around the world to share new research. Several studies stood out for their potential to change how certain types of non-small cell lung cancer (NSCLC) are treated. Here are three takeaways patients and caregivers should know.